Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1924664Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$673.1K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#15,952
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Mark Puder as a PI. Multi-PI records show the full award amount for context.
- 5R01FD006349-04R01A 90 day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children with Short Bowel Syndrome who are Dependent on Parenteral Nutrition$673.1Kaward amount
Award organization
Organizations that administered FY2026 awards listing Mark Puder as a PI.
FY2026 award administered by Boston Children's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardBoston Children's Hospital
- 2025R01 Grant Holder
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding